register free | resend password

Pressemitteilungen zu dem Thema genetic testing


Unterkategorien

PresseMitteilungen zu dem Schlagwort genetic testing


Qu Biologics Discovers Correlation Between Patient Genetics and Response to Immunotherapy in Inflammatory Bowel Disease

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 03/03/17 -- Qu Biologics Inc., a biopharmaceutical company developing (SSIs) that aim to "reboot" the body''s innate immune system, reports positive genetic analyses of their recently completed Phase 2 clinical studies in Crohn''s Disease (CD) and Ulcerative Colitis (UC). These findings suggest that, for the first time in the field of inflammatory bowel disease (IBD), personalized medicine and the application of gene ...


03.03.2017

Proove Biosciences Unveils First Precision Medicine Genetic Test for Painful TMJ Disorder

IRVINE, CA -- (Marketwired) -- 12/07/16 -- the Healthcare Decision Company™, is pleased to announce the introduction of its unprecedented test, designed to assist clinicians help treat patients with the difficult-to-treat, painful condition known as of temporomandibular joint disorder (TMD) -- which currently affects millions of Americans. This latest news marks Proove Biosciences'' next stride forward in using evidence-based and scientifically proven solutions to improve outcomes f ...


07.12.2016

Passing the Teal Torch to Raise Awareness This September During Ovarian Cancer Awareness Month

DENVER, CO -- (Marketwired) -- 09/12/16 -- For women with families with a history of ovarian or breast cancer, advances in genetic testing are saving lives. Knowing the likelihood of developing cancer can empower a woman to pursue treatment early rather than when it may be too late. Valarie Brehm, who received genetic testing in its early phases, credits it with saving her life and now she wants to educate other women about the importance of this important screening tool.In 2001, Brehm'� ...


12.09.2016

Newtopia''s Personalized Disease Prevention Program Opens Genetic Testing for All U.S. Companies

NEW YORK, NY -- (Marketwired) -- 11/04/15 -- Newtopia, a leading personalized health company that uses genetic testing and behavioral science to build highly personalized disease prevention plans for enterprise, today announces the wide availability of its program, including genetic testing, to all companies across the U.S. Newtopia recently completed successful pilots in this market and is offering its program to insurance companies and self-insured employers.Newtopia uses the information gath ...


04.11.2015

Harmonyx Releases Genetic Test That Examines Efficacy and Side Effects of Pain Medications

MEMPHIS, TN -- (Marketwired) -- 06/02/15 -- , a leading company in affordable and accessible genetic testing, has launched a new test that examines the efficacy and side effect risk of medications used to treat acute and chronic pain. Results from this test provide individualized details about which medication may be a good genetic match for the patient, along with guidance for dosing and potential side-effect risk.Americans report suffering from chronic pain. With the serious risks and side ef ...


02.06.2015

Diaceutics Group Launches Iceutics, Personalized Medicine Expert Resources for Targeted Therapy Commercialization Planning

BELFAST, UNITED KINGDOM -- (Marketwired) -- 05/14/15 -- Diaceutics Group, a dedicated integrator in personalized and precision medicine, leveraging analytics, software, services and consulting to enable the effective integration of therapies and diagnostics into the treatment pathway, today announced its Iceutics division has launched open source access to expert resources in personalized medicine () to support the industry in planning, launching and commercializing targeted therapies."The ...


14.05.2015

Harmonyx Releases Affordable ADHD Genetic Test

MEMPHIS, TN -- (Marketwired) -- 02/10/15 -- , a leading company in affordable and accessible genetic testing, has launched a new test for guided prescription therapy for Attention Deficit Hyperactivity Disorder (ADHD). The first-of-its-kind offering places power in patients'' hands by providing them with information regarding whether a medication will work for them or not. The test also allows physicians and pharmacists to make informed decisions about which medication will be most ef ...


10.02.2015

Reprogenetics Announces First Live Births Following Use of Novel Karyomapping Technique in Embryos Produced Through In Vitro Fertilization

LIVINGSTON, NJ -- (Marketwired) -- 01/29/15 -- Reprogenetics, one of the largest U.S. genetics laboratories specializing in Preimplantation Genetic Screening (PGS) and Preimplantation Genetic Diagnosis (PGD), today announced the arrival of the first babies born worldwide following the use of Karyomapping technology. This new approach allows PGD of most single gene disorders in embryos produced through in vitro fertilization (IVF). Karyomapping has substantially reduced the wait time for IVF cyc ...


29.01.2015

Harmonyx Places Power in Patients With New Payment Model and Website

MEMPHIS, TN -- (Marketwired) -- 01/13/15 -- , the leading company in affordable and accessible genetic testing, is aiming to change the way medicine is prescribed in America, with patients at the forefront. Harmonyx has left the insurance game and has implemented a progressive patient payment model, opening the door to anyone seeking personal guidance for their prescriptions. With this unique approach in its dedication to patients, Harmonyx is seeking to disrupt industry norms with a new focus ...


13.01.2015

New Report Reveals Most Leading Pharma Companies Still Not Commercially Ready for Personalized Medicine Business Model

NEW YORK, NY -- (Marketwired) -- 11/10/14 -- Diaceutics () today released the four year update to its Pharma Readiness for Personalized Medicine Report, which examines how prepared leading companies are for the emerging (PM) business model.The report reveals that leading pharmaceutical companies fall into two clear groups: those starting to build the internal and external capability for a personalized medicine predominant future, and those still on a learning curve. Within the twelve companies ...


10.11.2014

GENEWIZ, Inc. and ACCB Announce Collaboration for the Application of Next Generation Sequencing in Clinical Molecular Diagnostic Testing

SOUTH PLAINFIELD, NJ -- (Marketwired) -- 11/20/13 -- , leading global genomics service provider, and Beijing ACCB Biotech Ltd. (ACCB) announced a collaboration for the application of tests toward the advancement of clinical molecular diagnostics. The companies will partner to develop, validate, and commercialize genetic tests that deliver clinically relevant, medically actionable results.Based in Beijing, China, ACCB focuses on the development of novel molecular cancer detection and diagnostic ...


20.11.2013

InVitae Establishes an International Subsidiary and State-of-the-Art Genetic Testing Facility in Chile

SANTIAGO, CHILE -- (Marketwired) -- 05/30/13 -- InVitae Corporation announced today the establishment of a South American subsidiary, InVitae Chile SpA, and a partnership with biotechnology pioneer, Pablo Valenzuela and the Fundación Ciencia & Vida, to establish a production facility in Santiago, Chile. Dr. Valenzuela is a well-known biotechnology entrepreneur who co-founded Chiron in 1981 and the Fundación in 1997.The new entity is being formed to service global markets with genetic inform ...


30.05.2013

MMRGlobal Launches Telemedicine Patient Billing System and Adds Genomics File to PHR

LOS ANGELES, CA -- (Marketwired) -- 04/08/13 -- (OTCQB: MMRF) ("MMR"), a leading provider of ("PHRs"), storage solutions and electronic document management and imaging systems for , today announced a delivery system designed to bill for telemedicine services to patients through the Company's MyMedicalRecords Personal Health Record by charging additional fees on a per patient per month basis to employers, affinity group and membership organization clients as well as p ...


08.04.2013

Invivoscribe Launches Genection, a New Personalized Molecular Medicine Company Delivering Global Access to the Entire Clinically-Actionable Genetic Test Menu

SAN DIEGO, CA -- (Marketwire) -- 12/04/12 -- Invivoscribe Technologies, Inc., a privately-held life science company based in San Diego, California, announces the launch of .with a dedicated online platform for global access to the entire clinically-actionable , including both routine and esoteric genetic tests, exome and , cancer somatic mutation testing, and .Genection's model is not payor driven, so prescribing physicians have access to genetic tests that may currently be unavailable, ov ...


04.12.2012

American Academy of Ophthalmology Discourages Genetic Testing for Age-Related Macular Degeneration

CHICAGO, IL -- (Marketwire) -- 11/11/12 -- The today reiterated its position that at this time its member eye physicians and surgeons should avoid genetic testing for complex eye disorders such as and late-onset . The organization discourages patients from undergoing such testing until treatment or surveillance strategies can be shown to be of benefit to individuals with specific disease-associated genotypes and urges medical personnel to confine the genotyping of such patients to research st ...


11.11.2012



All members: 9 438
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 51


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.